Phorbol Ester Derivatives Modulating Cell Signaling for Reduced Toxicity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medicinal approaches face challenges in isolating and commercializing specific plant-derived compounds, such as phorbol esters, due to their complex composition and potential toxicity, limiting their effectiveness in treating chronic and acute conditions like HIV, cancer, and inflammatory diseases.
Innovation Solution
Compositions and methods utilizing phorbol esters and their derivatives to modulate cell signaling pathways, treat diseases, and manage symptoms by modifying HIV receptor activity, decreasing latent HIV reservoirs, and inhibiting HIV-cytopathic effects, while also addressing neoplastic diseases, chemotherapy side effects, and other conditions like stroke and rheumatoid arthritis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If phorbol esters are used to treat diseases, then therapeutic effectiveness is improved, but toxicity increases
Solution Approach 1:
The patent modifies the chemical structure of phorbol esters by changing parameters such as the ester chain length, saturation, and substitution patterns at positions 12 and 13 of the phorbol ring. These parameter changes create derivatives with reduced tumor-promoting activity and toxicity while maintaining or enhancing therapeutic effectiveness for treating HIV, cancer, and inflammatory diseases.
Solution Approach 2:
The patent extracts and isolates specific phorbol ester derivatives from plant sources or synthesizes them selectively to obtain pure compounds with desired therapeutic properties. This extraction process separates the beneficial therapeutic components from other plant constituents that may contribute to toxicity, allowing for controlled administration of the active compounds.
2Reliability
If plant-based medicinal compounds are isolated and commercialized, then treatment effectiveness is improved, but manufacturing complexity increases
Solution Approach 1:
The patent segments the complex plant extract into individual phorbol ester derivative compounds through systematic isolation and purification processes. This segmentation allows each active compound to be characterized, quantified, and manufactured separately, simplifying the overall manufacturing process while ensuring consistent quality and effectiveness.
Solution Approach 2:
The patent employs parameter changes in the isolation and purification processes, such as adjusting solvent systems, temperature conditions, and chromatographic parameters, to optimize the extraction and purification of phorbol ester derivatives. These parameter optimizations reduce manufacturing complexity by streamlining the isolation process from crude plant extracts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of phorbol esters and derivatives effectively treats a wide range of conditions by modulating cell signaling, reducing viral loads, increasing immune responsiveness, and alleviating symptoms and side effects, demonstrating novel and surprisingly effective treatment methods for chronic and recurring conditions.
Implementation Method 1
activate protein kinase C (PKC), modulating downstream cell signaling pathways including the mitogen-activated protein kinase (MAPK) pathways
Implementation Method 2
bind to chimaerins, the Ras activator RasGRP, and the vesicle-priming protein Munc-13
Implementation Method 3
induce nuclear factor-kappa B (NF-κB)
Data Source
AI summary
Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.